Sort   by:  
 Page size 
UnknownDurvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
Not available
S-EPMC8393812 | biostudies-literature
UnknownRelative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.
Not available
S-EPMC12820329 | biostudies-literature
UnknownSafety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.
Not available
S-EPMC5482731 | biostudies-literature
UnknownCopy number signatures and mutational processes in ovarian carcinoma.
Not available
S-EPMC6130818 | biostudies-literature
UnknownDevelopment and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
Not available
S-EPMC7572656 | biostudies-literature
UnknownPrognostic gene expression signature for high-grade serous ovarian cancer.
Not available
S-EPMC7484370 | biostudies-literature
Sort   by:  
 Page size